Abstract

The present study examined 962 global publications on Aegle marmelos, as covered in Scopus database during 2004-18, with a view to understand its growth rate, global share, citation impact, international collaborative papers share, distribution of publications by broad subjects, productivity and citation profile of top organizations and authors, preferred communication media and characteristics of high cited papers. Aegle marmelos global output registered 36.37% annual growth and averaged 16.0 citations per paper during the period. 43 countries participated in the global Aegle marmelos research output during 2004-18, of which the top 10 most productive countries contributed 98.97% global publication share and more than 100.0% global citation share. India alone contributed 82.30% of the global publication share, while all other 9 top countries contributed from 1.34% to 3.29% during 2004-18. Pharmacology, toxicology and pharmaceutics was the most followed subject with 47.71% global share, followed by medicine (29.0%), biochemistry, genetics and molecular biology (22.35%), agricultural and biological sciences (21.41%), etc. during 2004-18. Top 15 productive organizations and authors accounted for 19.65% and 12.79% global publications share and 22.85% and 21.30% global citations share in global Aegle marmelos research output. Top 15 most productive journals accounted for 19.68% of global publication share in journals. Only 32 publications registered high citations with 100-427 citations per paper and collectively averaging to 166.56 citations per paper. Suggest that the above analysis will help the policy-makers and scholars to explore the full potential of Aegle marmelos in preventing and treating diseases and also to identify future research areas in this field.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.